Healthy Living

Recent Breakthrough Increases Efficacy of Cystic Fibrosis Drugs

Positively manipulating results

After this initial stage of the study, the research were able to test how adding a quorum-basing inhibitor from the furanone family in vitro would have an effect. Brochiero said, "we showed that this molecule, by reducing the bacterial production of harmful residues, maintains treatment efficacy in the cells of patients with cystic fibrosis."